Company Long-Term Loans and Borrowings: Reviva Pharmaceuticals Holdings (RVPH)

Brandmark of Reviva Pharmaceuticals, Inc. (RVPH)

The Reviva Pharmaceuticals (RVPH) long-term liabilities chart on the GURU.Markets platform, which currently stands at 0.00, is based on the development of safe treatments for psoriasis and schizophrenia. Warehouse reserves guarantee the stability of component supplies for testing. However, the lack of profitability and uncertainty regarding the outcome of final-stage trials create serious financial threats for the company.

revivapharma.com (RVPH) Company Long-Term Debt: for the period 07/04/2022 - 05/16/2026

Reviva Pharmaceuticals Holdings - analytical breakdowns and key metrics (RVPH)

- market price and analyst price targets:
Stock Price revivapharma.com|RVPH - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Reviva Pharmaceuticals|RVPH - Total Company Value
- book capitalization information:
Net Asset Value per Share Reviva Pharmaceuticals|RVPH - Company Book Value|Market Value to Book Value revivapharma.com|RVPH - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Reviva Pharmaceuticals|RVPH - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Reviva Pharmaceuticals, Inc.|RVPH - Company Aggregate Debts|Debts to Net Assets Reviva Pharmaceuticals|RVPH - Company Long-Term Liabilities|Company Short-Term Debt Reviva Pharmaceuticals|Quick Ratio revivapharma.com
- earnings and market multiples details:
RVPH - Net Income
Summary company analytics:RVPH revivapharma.com
Manufactured product of Reviva Pharmaceuticals, Inc.

This indicator measures the total volume of long-term liabilities, allowing for an assessment of the capital structure's stability and the risk of credit pressure on the business. By analyzing the long-term debt history of Reviva Pharmaceuticals (RVPH), an investor can track borrowing trends, which is critical for Reviva Pharmaceuticals (RVPH) as the lack of operating revenue during the neuroleptic development stage makes the company dependent on external financing and the cost of debt service.

Competitor analysis for Reviva Pharmaceuticals

Company Long-Term Debts biogen.com BIIB|NBIX - Company Long-Term Debt|Company Long-Term Loans and Borrowings RGC (Regencell Bioscience Ltd)|Axsome Therapeutics Inc (AXSM) - Company Long-Term Debt|Long-Term Debt ACADIA Corp (ACAD)|Company Long-Term Debt Xenon Pharmaceuticals|VKTX: Company Long-Term Loans and Borrowings|Company Long-Term Debts SUPN|CPRX - Long-Term Debt|Denali Therapeutics Inc - Company Long-Term Liabilities|Harmony Corp - Company Long-Term Debt|Biohaven Ltd. - Company Long-Term Debts|Long-Term Debt Volume amylyx.com AMLX|TRVI (Trevi Therapeutics, Inc.) - Company Long-Term Liabilities|PRAX (Praxis Precision Medicines Inc) - Company Long-Term Debt|AVXL (Anavex Corp) - Company Long-Term Debts|Company Long-Term Debts CeriBell EEG|Company Long-Term Liabilities PRTA (Prothena)|ALEC (alector.com) - Company Long-Term Loans and Borrowings|Company Long-Term Debt Annexon ANNX|OMER (Omeros Corp) - Long-Term Liabilities|Neurogene Corp - Company Long-Term Debts|Company Long-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Long-Term Debts|neumoratx.com (NMRA) - Company Long-Term Debts|Company Long-Term Debt Scilex|TVGN: Company Long-Term Loans and Borrowings|Company Long-Term Debt Alpha Cognition (ACOG)|Company Long-Term Liabilities cogrx.com CGTX|Company Long-Term Debts IKT (Inhibikase Therapeutics)|Company Long-Term Debts cassavasciences.com SAVA|Assertio Therapeutics - Company Long-Term Debts|Coya Therapeutics, Inc. (COYA) - Company Long-Term Liabilities|VTGN: Company Long-Term Debts|Long-Term Debt Ovid Therapeutics (OVID)|Company Long-Term Liabilities ABOS|Company Long-Term Debts cervomed.com|Company Long-Term Liabilities ATHE (Alterity Therapeutics)|Amount of Long-Term Liabilities CLNN|Company Long-Term Debts PEPG (PepGen)|Long-Term Debt Volume jupiterneurosciences.com (JUNS)|Relmada Therapeutics - Company Long-Term Debts|annovisbio.com (ANVS) - Company Long-Term Liabilities|GRCE: Company Long-Term Debts|Firefly Neuroscience, Inc. (AIFF) - Company Long-Term Debts|Company Long-Term Debt ANEW Medical|Company Long-Term Debt NRSN|Company Long-Term Debt MetaVia Inc (MTVA)|Long-Term Debt Volume neuraxis.com|Company Long-Term Debt Helius Medical Technologies HSDT|Company Long-Term Loans and Borrowings PASG|NEUP: Company Long-Term Liabilities|NERV: Company Long-Term Debt|Athira Pharma, Inc. (ATHA) - Company Long-Term Debt|Long-Term Liabilities ADXN (addextherapeutics.com)|ALZN (Alzamend Neuro Inc.) - Company Long-Term Debts|CYCN: Company Long-Term Loans and Borrowings|Company Long-Term Debt Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Company Long-Term Indebtedness|Company Long-Term Debts CRGT (Cortigent)|avenuetx.com (ATXI) - Long-Term Debt|BCLI: Company Long-Term Liabilities|CARA - Company Long-Term Debts|Chromocell Therapeutics Corporation (CHRO) - Company Long-Term Debt|Eliem Therapeutics Inc. - Company Long-Term Loans and Borrowings|Company Long-Term Debt Intra-Cellular Therapies Inc.|Long-Term Debt longboardpharma.com LBPH|Company Long-Term Debt Marinus Pharmaceuticals, Inc. (MRNS)|NKGN (NKGen Biotech Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts NRBO (NeuroBo)|Sage Therapeutics Inc (SAGE) - Long-Term Debt|SNPX: Company Long-Term Liabilities|TRVN: Company Long-Term Debt|VIGL: Company Long-Term Debts|WENA - Long-Term Debt Volume|Company Long-Term Liabilities CERE